Andrew Turitz - Aug 30, 2024 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
EVP, CORPORATE DEVELOPMENT
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Stock symbol
TDOC
Transactions as of
Aug 30, 2024
Transactions value $
-$11,584
Form type
4
Date filed
9/4/2024, 04:11 PM
Previous filing
Jun 4, 2024
Next filing
Sep 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +1.06K +2.8% 38.7K Aug 30, 2024 Direct F1
transaction TDOC Common Stock Options Exercise +1.35K +3.48% 40.1K Aug 30, 2024 Direct F2
transaction TDOC Common Stock Options Exercise +3.1K +7.74% 43.2K Aug 30, 2024 Direct F2
transaction TDOC Common Stock Sale -$11.6K -1.62K -3.75% $7.16 41.5K Sep 3, 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Performance Stock Units Options Exercise $0 -1.06K -14.28% $0.00 6.34K Aug 30, 2024 Common Stock 1.06K Direct F1, F4
transaction TDOC Restricted Stock Units Options Exercise $0 -1.35K -33.33% $0.00 2.7K Aug 30, 2024 Common Stock 1.35K Direct F2, F5
transaction TDOC Restricted Stock Units Options Exercise $0 -3.1K -14.28% $0.00 18.6K Aug 30, 2024 Common Stock 3.1K Direct F2, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F3 Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
F4 The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F5 On March 1, 2022, the reporting person was granted 16,170 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F6 On March 3, 2023, the reporting person was granted 37,202 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.